Spike Medicine 22
  • Home

  • About Us

      • Company Profile

      • Enterprise culture

      • Qualification Honor

      • Chairman's Speech

  • News

      • Company Dynamics

      • Industry dynamics

  • Recruitment

  • Contact Us

      • Contact Information

      • Online message

  • Home

  • About Us

    • Company Profile

    • Enterprise culture

    • Qualification Honor

    • Chairman's Speech

  • News

    • Company Dynamics

    • Industry dynamics

  • Recruitment

  • Contact Us

    • Contact Information

    • Online message

+86-579-82131973
中文
NEWS

Feb 06,2013

Four ministries work together to promote the new revision of drug GMP to speed up the implementation


Key words:

Four ministries work together to promote the new revision of drug GMP to speed up the implementation

Feb 21,2013

Opinions on Consolidating and Improving the Essential Drug System and the New Mechanism of Basic Operation


Key words:

Opinions on Consolidating and Improving the Essential Drug System and the New Mechanism of Basic Operation

Mar 01,2013

Opinions on Deepening the Reform of Drug Review and Approval and Further Encouraging Drug Innovation


Key words:

Opinions on Deepening the Reform of Drug Review and Approval and Further Encouraging Drug Innovation

Mar 01,2013

Notice on the Relevant Matters of Drug Technology Transfer in the Process of Implementing the Newly Revised Pharmaceutical Production Quality Management Regulations


Key words:

Notice on the Relevant Matters of Drug Technology Transfer in the Process of Implementing the Newly Revised Pharmaceutical Production Quality Management Regulations

Mar 08,2013

Review and Approval Reform: Innovation and Breakthrough -- Interview with Wang Lifeng, Director of the Drug Registration Department of the State Food and Drug Administration


Key words:

Review and Approval Reform: Innovation and Breakthrough -- Interview with Wang Lifeng, Director of the Drug Registration Department of the State Food and Drug Administration

Mar 08,2013

Remind attention to the risk of Chinese and Western medicine compound preparation Zhenju antihypertensive tablets


Key words:

Remind attention to the risk of Chinese and Western medicine compound preparation Zhenju antihypertensive tablets
< 1234...61 >
contact Contact
tel +86-579-82131973
tel gs@zjifyy.com.cn
Whatsapp
top TOP
Chenglian Medicine

Follow us

  • Home

  • About Us

    • Company Profile

    • Enterprise culture

    • Qualification Honor

    • Chairman's Speech

  • News

    • Company Dynamics

    • Industry dynamics

  • Recruitment

  • Contact Us

    • Contact Information

    • Online message

Zhejiang Jianfeng Pharmaceutical Co., Ltd.

Sales Line:

+86-579-82131973
Mailbox:gs@zjifyy.com.cn
Company address: No.88, Wujiang East Road, Jinhua City, Zhejiang Province

Copyright©2023 Zhejiang Jianfeng Pharmaceutical Co., Ltd

Powered by www.300.cn | SEO  | Business License

SAF Coolest v1.3.1.1 设置面板XRBSX-ZEJN-JAAZE-ZWD

图片ALT信息: JIANFENG

无数据提示

Sorry, the current column is being updated, please look forward to it!

You can view other columns or returnHome Page